Eagle Pharmaceuticals (EGRX), NIH/NIDA Enter Agreement for Ryanodex Usage in Ecstasy and Methamphetamine Intoxication
Tweet Send to a Friend
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that it has entered into an agreement with the National Institutes of Health (“NIH”)/National ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
